Forecasts

Pfizer : PFE

PFE

Stock Data

$25.65

$0.02 (0.08%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Pfizer Inc. is a global leader in biopharmaceuticals, offering a wide range of medicines and vaccines. The company focuses on various therapeutic areas including cardiovascular, infectious diseases, women’s health, chronic immune and inflammatory diseases, and more. Pfizer is known for its significant contributions to COVID-19 prevention and treatment with products like Comirnaty and Paxlovid. It also has a strong portfolio in biosimilars and innovative treatments across other serious health conditions. Founded in 1849 and based in New York, Pfizer collaborates with several other healthcare giants to improve global health.

All Pfizer Articles

1446 Articles

Joel South | Yesterday

Snowflake (NYSE: SNOW) Price Prediction and Forecast 2026–2030 (February 2026)

Shares of cloud-based storage solutions provider Snowflake Inc. (NYSE: SNOW) lost 6.93% over the past month after losing 6.26% and…

Lee Jackson | Jan 8, 2026 at 8:41 AM EST

Fed Governor Wants Huge Rate Cuts This Year: 5 High-Yield Dividend Stocks to Buy Today

These five high-yield dividend stocks with solid upside potential and Buy ratings make sense for growth and income investors now.

Vandita Jadeja | Dec 29, 2025 at 12:35 PM EST

Jim Cramer Names His Favorite Dividend Stocks

Jim Cramer has built a strong reputation in the industry. He’s the Mad Money host who carefully picks growth stocks…

Omor Ibne Ehsan | Dec 24, 2025 at 7:48 AM EST

3 Under-The-Radar Dividend Stocks to Buy on the Cheap

Dividend stocks have been under pressure in the past few years due to the broader economy’s unpredictable swings. General Mills…

Michael Williams | Dec 10, 2025 at 10:47 AM EST

This Invesco ETF Pays a 4.71% Yield With 50 Low-Volatility Dividend Stocks (3x the S&P 500)

Invesco High Dividend Low Volatility ETF (NYSEARCA:SPHD) generates its 4.71% yield – roughly three times the S&P 500’s current dividend…

William Temple | Dec 6, 2025 at 8:52 AM EST

Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue

Pfizer (NYSE: PFE) and Teva Pharmaceutical Industries (NYSE: TEVA) just reported third-quarter earnings that reveal two pharmaceutical companies moving in…

Lee Jackson | Dec 2, 2025 at 8:42 AM EST

Our December High-Yield 6% Dividend Stocks Have Big Total Return Potential

These five stocks are potential total return champions that could offer investors a smooth ride in 2026, as we could…

Douglas A. McIntyre | Nov 21, 2025 at 8:34 AM EST

The Great S&P 500 Shakeup Leaves Microsoft and Oracle the Last Giants Standing

Watch the VideoI began the conversation with Lee by noting how rarely investors stop to consider how dramatically the upper…

Douglas A. McIntyre | Nov 20, 2025 at 9:15 AM EST

Wall Street Gives Up on High-Yield Stocks

When the AI bubble bursts, Altria will look like a pretty good investment again. It has paid out billions in…

Vandita Jadeja | Nov 11, 2025 at 9:53 AM EST

5 Highest Yielding Dividend Stocks in the S&P 500

The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high…

Lee Jackson | Nov 10, 2025 at 8:11 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More

Pre-Market Stock Futures:  The futures are trading higher as the new week begins, with most investors and traders relieved that…

Vandita Jadeja | Nov 6, 2025 at 11:36 AM EST

No Brainer Dividend Stocks To Buy Now

You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a…

Lee Jackson | Nov 4, 2025 at 2:43 PM EST

Our Top November High-Yield Picks Pay Reliable 7%-9% Dividends

Our five top November high-yield picks have solid forward momentum and should hold their ground well, even if we experience…

Joel South | Nov 4, 2025 at 9:54 AM EST

Pfizer’s Q3 Earnings Beat on Top and Bottom Lines

Pfizer (NYSE: PFE) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue…

Rich Duprey | Nov 3, 2025 at 10:13 AM EST

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that…